• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, December 4, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

New research shows promise to treat female group A streptococcus genital tract infections

Bioengineer by Bioengineer
March 19, 2020
in Biology
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Investigators have identified novel group A streptococcus surface proteins contributing to female reproductive tract infection that may help develop vaccines for preventing diseases such as childbed fever, reports The American Journal of Pathology

IMAGE

Credit: Dr. Frank DeLeo (National Institute of Allergy and Infectious Diseases)

Philadelphia, March 19, 2020 – Puerperal sepsis, also known as childbed fever, is the leading cause of maternal deaths. In this novel study in The American Journal of Pathology, published by Elsevier, scientists report on the discovery of group A streptococcus (GAS) surface proteins involved in female reproductive tract infections such as puerperal sepsis that may pave the way to developing vaccines and more effective treatments.

GAS is a major pathogen causing more than 700 million human infections a year worldwide and 15 million cases each year in the United States. Although the main site of infection is in the throat, GAS can also colonize the female genital tract and cause severe neonatal infections and diseases in the mother during and after labor such as puerperal sepsis. Both GAS neonatal infections and puerperal sepsis have high morbidity and mortality rates. However, after more than 100 years of study, there is still no licensed GAS vaccine available.

“We are still way behind the curve of understanding the molecular basis of puerperal sepsis,” explained lead investigator James M. Musser, MD, PhD, chair of the Department of Pathology and Genomic Medicine at Houston Methodist Hospital and the Fondren Presidential Distinguished Chair at the Houston Methodist Research Institute, Houston, TX, USA. “Our understanding of GAS genes contributing to interaction with the female genital tract is a knowledge desert, in part because of limited relevant animal models. It is therefore an important area for translational research to develop vaccines or treatments.”

Investigators developed two new animal models for the study of GAS infection biology and used transposon mutant library screens to identify pathogen genes contributing to colonization of the vaginal tract mucosa and infection in the uterine wall. They identified 69 GAS genes required for colonization of the vaginal mucosa in animal models and 96 genes required for infection of the uterine wall ex vivo. They discovered a common set of 39 genes important for GAS fitness in both environments. Notably, they found that genes encoding surface protein SpyAD, and immunogenic secreted protein Isp2, are crucial for GAS fitness in the female genital tract. These warrant translational research that may lead to developing effective new treatments and vaccines and perhaps novel diagnostics.

“This research takes us a step closer toward resolving a long-standing gender health disparity,” noted Dr. Musser. “It is the first time we have been able to address this neglected area of research into puerperal sepsis occurring before, during, and after labor.

“Such studies could make important contributions to our understanding of the molecular basis of puerperal sepsis, a disease that has an unusually rich history in medicine because of the pioneering studies by the physician and scientist Ignaz Semmelweis,” he concluded.

The Hungarian physician and scientist Ignaz Semmelweis (1818-1865) discovered that the incidence of puerperal fever could be drastically reduced by the use of hand disinfection in obstetric clinics. Despite publication of results in which hand-washing reduced mortality to below one percent, his ideas were initially rejected. The practice only earned widespread acceptance after his death.

###

Media Contact
Eileen Leahy
[email protected]
732-238-3628

Related Journal Article

http://dx.doi.org/10.1016/j.ajpath.2019.12.003

Tags: Death/DyingGynecologyInfectious/Emerging DiseasesMedicine/HealthMolecular Biology
Share13Tweet8Share2ShareShareShare2

Related Posts

blank

Rice miRNA: Key Regulator in Fungal Interactions

December 3, 2025
Human Impact Alters Leopard and Ungulate Dynamics

Human Impact Alters Leopard and Ungulate Dynamics

December 3, 2025

Adaptive Microsatellite Variants in Indian Yak Populations

December 2, 2025

Guide to Single-Cell RNA Transcriptomics Unveiled

December 2, 2025
Please login to join discussion

POPULAR NEWS

  • New Research Unveils the Pathway for CEOs to Achieve Social Media Stardom

    New Research Unveils the Pathway for CEOs to Achieve Social Media Stardom

    204 shares
    Share 82 Tweet 51
  • Scientists Uncover Chameleon’s Telephone-Cord-Like Optic Nerves, A Feature Missed by Aristotle and Newton

    120 shares
    Share 48 Tweet 30
  • Neurological Impacts of COVID and MIS-C in Children

    107 shares
    Share 43 Tweet 27
  • MoCK2 Kinase Shapes Mitochondrial Dynamics in Rice Fungal Pathogen

    69 shares
    Share 28 Tweet 17

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Boosting Cancer Immunotherapy by Targeting DNA Repair

Evaluating eGFR Equations in Chinese Children

Metformin-Alogliptin Combo vs. Monotherapy in Diabetes

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 69 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.